MINISTRY OF HEALTH. THE CRIM INAL JUSTICE (INTERNATIONAL SI. No. 110 of 2000 CO-OPERATION) ACT, (No.42 of 2000)

Transcription

1 MINISTRY OF HEALTH THE CRIM INAL JUSTICE (INTERNATIONAL SI. No. 110 of 2000 CO-OPERATION) ACT, 2000 (No.42 of 2000) THE CRIMINAL JUSTICE (INTERNATIONAL CO-OPERATION) REGULATIONS, 2000 The Minister, in exercise of the powers conferred by section 14(5) of the Criminal Justice (International Co-operation) Act, 2000, makes the following regulations Citation. 1. These Regulations may be cited as the Criminal Justice (Classes A, B and C Drugs) Regulations, Drugs: 2. Class A, Class B and Class C drugs for the Classes A, purpose of subsection (4) of section 14 of the Criminal B and C. Justice (International Co operation) Act 2000 are those respectively listed in Parts I, II and III of the Schedule to these Regulations. SCHEDULE (Regulations 2) PART I CLASS A DRUGS 1. The following substances and products, namely- (a) ACETORPHINE ALE ENTANIL ALLYLPRODINE ALPHACETYLMETH ADOL

2 -2- ALPHAMEPRODINE ALPHAMETHADOL ALPRAPRODINE ANILERIDINE BENZETHIDINE BENZYLMORPHINE (3 Benzylmorphine) BETACETYLMETHADOL BE TAME PROD IN E BETAMETHADOL BETAPRODINE BEZITRAMIDE BUFOTENINE CANNABINOL DERIVATIVES CANNABINOL except where contained in Cannabis or Cannabis resin CARFENTANIL CLONITAZENE COCA LEAF COCAINE

3 -3- DESOMORPHINE DEXTROMORAMI DE DIAMORPHINE DIAMPROMI DE DIETHYLTHIANBUTENE DIFENOXIN (l- (3- cyano-3,3- diphenylpropyl)-4- phenylpiperidine-4- carboxylic acid) DIHYDROCODEINO NE 0- CARBOXYMETHYLO XIME DIHYDRONORPHINE E DIMENOX.ADOLE DIMEPHEPTANOL DIMETHYLTHIAF4BUTENE DIOXAPHETYL BUTYRATE DIPHENOXYLATE DIPIPAN0NE DR0TEBAN0L ECG0NINE (3,4-dimethoxy-17- methylmorphinan 6B, 14 diol) and any derivative of ecgonine which is convertible to ecgonine or to cocaine

4 -4- ETHYLMETHYLTHIA MBUTANE ETICYCLIDINE ETONITAZENE ETORPHINE ETOXERIDINE FENTANYL FURETHIDINE HYDROCODONE HYDROMORPHINOL HYDROMORPHONE HYCROXYPETHI DINE ISOMETHADONE KETOBEMI DONE LEVOMETHORPHAN LEVOMORAMI DE LEVOPHENACY LMORPHAN LEVORPHANOL LOFENTANIL LYSERGAMIDE

5 -5- LYSERGIDE and other N alkyl derivatives of lysergamide MESCALINE METAZOCINE METHADONE METHADY L ACETATE METHYLAMINOREX METHYLDESORPHINE METHYLDIHYDROMORPHINE METOPON MORPHERIDINE (6-rnethyldihydromorphine) MORPHINE MORPHINE METHOBROMIDE, morphine n- oxide and other pentavalent nitrogen morphine derivatives MYROPHINE N, N- DIETHYLTRYPTAMINE N, N- DIMETHYLTRYPTAMINE N-HYDROXYTENANPHETANINE (Nhydroxy MDA)

6 -6- NICOMORPHINE (3, 6-dinicotinoylmorphine) NORACYMETHADOL NORLEVOR PHANO L NOP.MET HA DONE NORMORPHINE NORPI PANONE OPIUM whether raw, prepared or medicinal OXYCODONE OXYMORPHONE PETHIDINE PHENAD OXONE PHENANPROMI DE PHENAZOCINE PHENCYCLIDINE PHENOMORPH.AN PHENOPERIDINE PIMINODINE PIRITRAMIDE POPPY-STRAW and concentrate of poppystraw PROHEPTAZINE

7 -7- PROPERIDINE ) l-methyl-4-phenylpiperidine 4 carboxylic acid isopropyl ester) PSILOCIN RACEMETHORPHAN RACEMORAMIDE RACEMORPHAN ROLYCYCLIDINE SUFENTANIL TENOCYCLIDINE THEBACON THEBAINE TILIDATE TRIMEPERIDINE 4 -BROMO-2, 5-DIMETHOXY-x- METHYLPHENETHYLAMINE 4-CYANO-2-DIMETHYLAMINO-4, 4 DIPHENYLBUTANE 4-CYANO- 1-METHYL-4-PHENYLPIPERDINE 2, 5-DIMETHOXY-x, 4- DIMETHYLPHENETHYLAMINE 2-METHYL- 3-MORPHOLINO-l, 1-

8 -8- DIPHENYLPROPANECARBOXYLIC ACID 1-METHYL-4-PHENYLPIPERIDINE 4- CARBOXYLIC ACID 4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER )norpethidine) (b) any compound (not being a compound for the time being specified in sub-paragraph (a)) structurally derived from tryptamine or from a ring hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent; (c) any compound (not being methoxyphenamine or a compound for the time being specified in sub paragraph (a) above) structurally derived from phenethylamine, an N-alkylphenethylamine, methylphenethylalflime, and N-Alkyl x- methylphenethylarfline, or an N-alkyl x ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substrtuents, whether or not further substituted in the ring by one or more other univalent suhstitutents; (d) any compound (not being a compound for the time being specified in sub paragraph (a) ( structurally derived from fentanyl by modification in any of the following ways, that is to say (i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle, (ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups, (iii) by substitution in the piperidine ring with alkyl or alkenyl groups,

9 -9- (iv) (v) by substitution in the aniline ring with alkyl, alkoxy alkylenedioxy, halogeno or haloalkyl groups, by substitution at the 4 position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group; (e) (i) any compound (not being a compound for the time being specified in sub paragraph (a) ) structurally derived from pethidine by modification in any of the following ways, that is to say by replacement of the 1 methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted, (ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propane bridge, whether or not further substituted, (iii) by substitution in the 4 phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups, (iv) by replacement of the 4 ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group, (v) by formation of a N oxide or of a quaternary base. 2. Any stereoisomeric form of a substance for the time being specified in paragraph 1 not being dextromethorphan or dextrorphan. 3. Any ester or ether or a substance for the time being specified in paragraph 1 or 2 not being a substance for the time being specified in Part II of this Schedule.

10 Any salt of a substance for the time being specified in any of paragraphs 1 to Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to Any preparation designed for administration by injection specified in any of paragraphs 1 to 3 of Part II of this Schedule. PART II CLASS B DRUGS 1. The following substances and products, namely (a) ACETYLDIHYDROCODEINE AMPHETAMINE CANNABIS AND CANNABIS RESIN CODEINE DIHYDROCODEINE ETHYLMORPHINE (3-ethylmorphine) GLUTETHIMI DE LEEETAMINE MECLOQUALONE METHAQUALONE

11 -11- METHYLAMPHETAMINE METHYLPHENI DATE METHYLPHENOBARBITONE NICOCODINE NICODICODINE (6-nicotinoyldihydrocodine) NORCODEINE PENTAZOCINE PHENMETRAZINE PHOLCODINE PROP IRAN (b) any 5,5 disubstituted barbituric acid. 2. Any stereoisomeric form of a substance for the time being specified in paragraph Any salt of a substance for the time being specified in paragraph 1 or Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3, not being a preparation falling within paragraph 6 of Part I. PART III CLASS C DRUGS 1. The following substances and products, namely ALPRAZOLAM BENZPHETANINE BROMAZEPAM

12 -12- BUPRENORPHINE CAMAZEPAM CATHINE CATHINONE CHLORDIAZEPOXIDE CHLORPHENTERMINE CLOBAZAM CLONAZEPAM CLORAZEPIC AcID CLOTIAZEPAM C LOXAZOLAM DELORAZEPAM DEXTROPROPOXYPHENE DIAZEPAM DIETHYLPROPION ESTAZOLAM ETHCHLORVYNOL ETHINAMATE ETHYL LOFLAZEPATE F ENCANFAMIN FENETHYLLINE FENPROPOREX

13 -13- FLUDIAZEPAM FLUNITRAZEPAM FLURAZEPAM HALAZEPAM HALOXAZOLAM KETAZOLAM LOPRAZOLAM LORAZEPAM LORMETAZ E PAM MAZINDOL MEDAZEPAM MEFENOREX MEPHENTERMINE MEPROBAMATE ME THYPRYLONE MIDAZOLAM N-ETHYLAMPHETAMINE NIMETAZEPAM NITRAZEPAM NORDIAZEPAM OXAZEPAM

14 -14- OXAZOLAM PEMOLINE PHENDIMETRAZINE PHENTERMINE PINAZEPAM PIPRADROL PRAZEPAM PROPYLHEXEDRINE PYROVALERONE TEMAZEPAM TETRAZEPAM TRIAZOLAM 2. Any stereojsomeric form of a substance for the time being specified in paragraph 1, not being phenylpropanolamine. 3. Any salt of a substance for the time being specified in paragraph 1 or Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3. Made this 29th day of December, Signed RONALD L. KNOWLES Minister responsible for Health